According to a new market report published by Lucintel, the future of the nerve repair and regeneration market looks promising with opportunities in the hospitals and clinics and ambulatory surgery center. The nerve repair and regeneration market is expected to grow with a CAGR of 13% from 2019 to 2024. The major drivers for this market are high incidence of nerve injuries, rising geriatric population and subsequent growth in the prevalence of neurological disorders.
To download report brochure, please go to https://www.lucintel.com/nerve-repair-and-regeneration-market.aspx and click "report brochure" tab from the menu.
In this market, neurostimulation and neuromodulation devices and biomaterials are the major product type. Neurostimulation and neuromodulation devices are the largest segment of the nerve repair and regeneration market.
Neurostimulation and neuromodulation surgeries, direct nerve repair/ neurorrhaphy, nerve grafting, and stem cell therapy are the major application of the nerve repair and regeneration market. Stem cell therapy is the largest segment of the nerve repair and regeneration market.
North America will remain the largest region over the forecast period due to increasing incidence of neurological disorders and supportive health insurance coverage scenario in the region and availability of technologically advanced devices owing to the presence of major market players.
Axogen, Baxter, Boston Scientific, Livanova, Integra Lifesciences, Medtronic, Abbott Laboratories, Stryker, Polyganics, Nuvectra, Neuropace, Orthomed, and Nevro are among the major manufacturers of nerve repair and regeneration.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the nerve repair and regeneration market by product, application, end user, and region. Lucintel has prepared a comprehensive research report titled "Nerve Repair and Regeneration Market 2019-2024: Trends, Forecast, and Opportunity Analysis". The Lucintel report serves as a catalyst for growth strategy as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the nerve repair and regeneration market by product, application, end user, and region as follows:
By Product [$M shipment analysis for 2013 – 2024]:
Neurostimulation and Neuromodulation Devices
Biomaterials
By Application [$M shipment analysis for 2013 – 2024]:
Neurostimulation and Neuromodulation Surgeries
Direct Nerve Repair/ Neurorrhaphy
Nerve Grafting
Stem Cell Therapy
By End User [$M shipment analysis for 2013 – 2024]:
Hospitals and Clinics
Ambulatory Surgery Center
By Region [$M shipment analysis for 2013 – 2024]:
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
France
Italy
Spain
Asia-Pacific
ROW
This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/nerve-repair-and-regeneration-market.aspx or helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com